Abstract
Arterial spin labeling (ASL) is a type of MR perfusion imaging which utilizes magnetically labeled arterial blood as an intrinsic tracer. Because ASL involves no radioactive tracers or contrast administration, it is considered to be completely noninvasive. Moreover, ASL theoretically allows for quantitative measurement of regional cerebral blood flow (rCBF). However, ASL suffers from technical limitations including low signal-to-noise ratio and high sensitivity to arterial transit time inhomogeneity. A variety of ASL pulse sequences have been proposed, which are categorized into pulsed ASL and continuous ASL sequences. Maps of rCBF obtained with ASL are typically analyzed quantitatively, often using image statistical methods. Typical ASL findings of Alzheimer’s disease include hypoperfusion in the cortical areas of the posterior cingulate and precuneus as well as the temporoparietal association cortex. Several studies have shown that ASL has high diagnostic performance in discriminating patients with Alzheimer’s disease and healthy elderly subjects, although its clinical roles in diagnosing dementia have not been established.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Rosen BR, Belliveau JW, Aronen HJ, et al. Susceptibility contrast imaging of cerebral blood volume: human experience. Magn Reson Med. 1991;22:293–9.
Williams DS, Detre JA, Leigh JS, Koretsky AP. Magnetic resonance imaging of perfusion using spin inversion of arterial water. Proc Natl Acad Sci U S A. 1992;89:212–6.
Detre JA, Leigh JS, Williams DS, Koretsky AP. Perfusion imaging. Magn Reson Med. 1992;23:37–45.
Buxton RB, Frank LR, Wong EC, Siewert B, Warach S, Edelman RR. A general kinetic model for quantitative perfusion imaging with arterial spin labeling. Magn Reson Med. 1998;40:383–96.
Ye FQ, Berman KF, Ellmore T, et al. H(2)(15)O PET validation of steady-state arterial spin tagging cerebral blood flow measurements in humans. Magn Reson Med. 2000;44:450–6.
Heijtel DF, Mutsaerts HJ, Bakker E, et al. Accuracy and precision of pseudo-continuous arterial spin labeling perfusion during baseline and hypercapnia: a head-to-head comparison with 15O H2O positron emission tomography. NeuroImage. 2014;92:182–92.
Kimura H, Kado H, Koshimoto Y, Tsuchida T, Yonekura Y, Itoh H. Multislice continuous arterial spin-labeled perfusion MRI in patients with chronic occlusive cerebrovascular disease: a correlative study with CO2 PET validation. J Magn Reson Imaging. 2005;22:189–98.
Ye FQ, Mattay VS, Jezzard P, et al. Correction for vascular artifacts in cerebral blood flow values measured by using arterial spin tagging techniques. Magn Reson Med. 1997;37:226–35.
Hendrikse J, Petersen ET, van Laar PJ, Golay X. Cerebral border zones between distal end branches of intracranial arteries: MR imaging. Radiology. 2008;246:572–80.
Jahng G-H, Song E, Zhu X-P, Matson GB, Weiner MW, Schuff N. Human brain: reliability and reproducibility of pulsed arterial spin-labeling perfusion MR imaging. Radiology. 2005;234:909–16.
Petersen ET, Mouridsen K, Golay X, et al. The QUASAR reproducibility study, part II: results from a multi-center arterial spin labeling test-retest study. NeuroImage. 2010;49:104–13.
Chen Y, Wang DJJ, Detre JA. Test-retest reliability of arterial spin labeling with common strategies. J Magn Reson Imaging. 2011;33:940–9.
Günther M, Bock M, Schad LR. Arterial spin labeling in combination with a look-locker sampling strategy: inflow turbo-sampling EPI-FAIR (ITS-FAIR). Magn Reson Med. 2001;46:974–84.
Petersen ET, Lim T, Golay X. Model-free arterial spin labeling quantification approach for perfusion MRI. Magn Reson Med. 2006;55:219–32.
Dai W, Garcia D, de Bazelaire C, Alsop DC. Continuous flow-driven inversion for arterial spin labeling using pulsed radio frequency and gradient fields. Magn Reson Med. 2008;60:1488–97.
WC W, Fernandez-Seara M, Detre JA, Wehrli FW, Wang J. A theoretical and experimental investigation of the tagging efficiency of pseudocontinuous arterial spin labeling. Magn Reson Med. 2007;58:1020–7.
Alsop DC, Detre JA, Golay X, et al. Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: A consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia. Magn Reson Med. 2014;73(1):102–16. doi:10.1002/mrm.25197.
Sandson TA, O’Connor M, Sperling RA, et al. Noninvasive perfusion MRI in Alzheimer’s disease: a preliminary report. Neurology. 1996;47:1339–42.
Alsop DC, Detre JA, Grossman M. Assessment of cerebral blood flow in Alzheimer’s disease by spin-labeled magnetic resonance imaging. Ann Neurol. 2000;47:93–100.
Johnson NA, Jahng G-H, Welner MW, et al. Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience. Radiology. 2005;234:851–9.
Kogure D, Matsuda H, Ohnishi T, et al. Longitudinal evaluation of early Alzheimer’s disease using brain perfusion SPECT. J Nucl Med. 2000;41:1155–62.
Ishii K, Sasaki M, Yamaji S, Sakamoto S, Kitagaki H, Mori E. Demonstration of decreased posterior cingulate perfusion in mild Alzheimer’s disease by means of H2 15O positron emission tomography. Eur J Nucl Med. 1997;24:670–3.
Asllani I, Habeck C, Scarmeas N, Borogovac A, Brown TR, Stern Y. Multivariate and univariate analysis of continuous arterial spin labeling perfusion MRI in Alzheimer’s disease. J Cereb Blood Flow Metab. 2008;28:725–36.
Yoshiura T, Hiwatashi A, Noguchi T, et al. Arterial spin labelling at 3-T MR imaging for detection of individuals with Alzheimer’s disease. Eur Radiol. 2009;19:2819–25.
Binnewijzend MA, Kuijer JP, Benedictus MR, et al. Cerebral blood flow measured with 3D pseudocontinuous arterial spin-labeling MR imaging in Alzheimer disease and mild cognitive impairment: a marker for disease severity. Radiology. 2013;267:221–30.
Xu G, Rowley HA, Wu G, et al. Reliability and precision of pseudo-continuous arterial spin labeling perfusion MRI on 3.0 T and comparison with 15O-water PET in elderly subjects at risk for Alzheimer’s disease. NMR Biomed. 2010;23:286–93.
Chen Y, Wolk DA, Reddin JS, et al. Voxel-based comparison of arterial spin-labeled perfusion MRI and FDG-PET in Alzheimer disease. Neurology. 2011;77:1977–85.
Musiek ES, Chen Y, Korczykowski M, et al. Direct comparison of fluorodeoxyglucose positron emission tomography and arterial spin labeling magnetic resonance imaging in Alzheimer’s disease. Alzheimers Dement. 2012;8:51–9.
Alsop DC, Casement M, de Bazelaire C, Fong T, Press DZ. Hippocampal hyperperfusion in Alzheimer’s disease. NeuroImage. 2008;42:1267–74.
Mak HK, Qian W, Ng KS, et al. Combination of MRI hippocampal volumetry and arterial spin labeling MR perfusion at 3-Tesla improves the efficacy in discriminating Alzheimer’s disease from cognitively normal elderly adults. J Alzheimers Dis. 2014;41:749–58.
Bron EE, Steketee RM, Houston GC, et al. Alzheimer’s disease neuroimaging initiative. Diagnostic classification of arterial spin labeling and structural MRI in presenile early stage dementia. Hum Brain Mapp. 2014;35:4916–31.
Chao LL, Buckley ST, Kornak J, et al. ASL perfusion MRI predicts cognitive decline and conversion from MCI to dementia. Alzheimer Dis Assoc Disorder. 2010;24:19–27.
Du AT, Jahng GH, Hayasaka S, et al. Hypoperfusion in frontotemporal dementia and Alzheimer disease by arterial spin labeling MRI. Neurology. 2006;67:1215–20.
WT H, Wang Z, Lee VM, Trojanowski JQ, Detre JA, Grossman M. Distinct cerebral perfusion patterns in FLD and AD. Neurology. 2010;75:881–8.
Dashjamts T, Yoshiura T, Hiwatashi A, et al. Simultaneous arterial spin labeling cerebral blood flow and morphological assessments for detection of Alzheimer’s disease. Acad Radiol. 2011;18:1492–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Japan
About this chapter
Cite this chapter
Yoshiura, T. (2017). Arterial Spin Labeling in Dementia. In: Matsuda, H., Asada, T., Tokumaru, A. (eds) Neuroimaging Diagnosis for Alzheimer's Disease and Other Dementias. Springer, Tokyo. https://doi.org/10.1007/978-4-431-55133-1_6
Download citation
DOI: https://doi.org/10.1007/978-4-431-55133-1_6
Published:
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-55132-4
Online ISBN: 978-4-431-55133-1
eBook Packages: MedicineMedicine (R0)